Bolt Biotherapeutics lines up two investor conferences
Alpha Vantage · The Manila Times · · AI-summarised by FinFlash
Bolt Biotherapeutics (Nasdaq: BOLT) will present at the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference, with Chief Strategy Officer Sheila Gujrathi, M.D., detailing pipeline updates including lead program PRA-216. The company recently completed a reverse merger with Prana Therapies and raised Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context